Vitamin D Therapy Global Market Report 2023

“Vitamin D Therapy Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vitamin d therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for vitamin d therapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The vitamin d therapy market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Administration: Oral; Parenteral

• 2) By Purchasing: OTC Drugs; Prescription Grugs

• 3) By Age Group: Children; Adults; Senior Adults

• 4) By Application: Osteoporosis; Rickets; Skin Diseases; Muscle Weakness; Autoimmune Disorders

• Companies Mentioned: Abbott Laboratories; Sanofi SA; Glaxo Smith Kline; Pfizer Inc.; Merck and Co. Inc.

• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

• Time series: Five years historic and ten years forecast.

• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the vitamin d therapy market are Abbott Laboratories, Sanofi SA, Glaxo Smith Kline, Pfizer Inc., Merck and Co. Inc., Torrent Pharmaceuticals Ltd., Novartis International AG, Alkem Laboratories, Sun Pharmaceutical Industries Ltd., Cadila Healthcare Ltd., Biotics Research Corporation, Solvay Pharma India Pvt. Ltd., Forgo Pharmaceuticals Ltd., Mankind Pharmaceuticals Pvt. Ltd., and Cipla Ltd.

The global vitamin D therapy market is expected to grow from $2.34 billion in 2022 to $2.62 billion in 2023 at a compound annual growth rate (CAGR) of 11.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The vitamin D therapy market is expected to grow to $4.09 billion in 2027 at a CAGR of 11.7%.

The vitamin D therapy market consists of sales of plain vitamin D therapy and active vitamin D analog (or D-hormone) therapy. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Vitamin D therapy refers to supplements that are commonly used to treat and prevent vitamin D deficiency. Vitamin D therapy helps regulate calcium and phosphorus in the body. It also plays a role in maintaining proper bone structure. Vitamin D supplementation may help people with depression who also have a vitamin D deficiency.

North America was the largest region in the vitamin D therapy market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vitamin D therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The administration involved in vitamin D therapy are oral and parenteral. Oral refers to entering the body through the mouth. The various purchasing involved are OTC drugs and prescription drugs that are used by various age groups such as by children, adults, and senior citizens for osteoporosis, rickets, skin diseases, muscle weakness, and autoimmune disorder applications.

An increased prevalence of malnutrition cases is expected to propel the growth of the vitamin D therapy market going forward. Malnutrition refers to deficiencies or excesses in nutrient intake, imbalances of essential nutrients, or impaired nutrient utilization. Vitamin D deficiency is highly prevalent in the population of malnourished inpatients and is negatively associated with long-term mortality, particularly when patients are not receiving vitamin D treatment. Thus, the increased prevalence of malnutrition cases creates demand for vitamin D therapy. For instance, in June 2021, according to an article by the World Health Organization, a Switzerland-based agency working to promote health, keep the world safe, and serve the vulnerable, around 1.9 billion adults are overweight or obese, while 462 million are underweight globally in 2020, And around 149 million children under 5 were estimated to be stunted, 45 million were estimated to be wasted, and 38.9 million were overweight or obese. Therefore, the increasing prevalence of malnutrition cases is driving the growth of the vitamin D therapy market.

Product innovations are a key trend gaining popularity in the vitamin D therapy market. Major companies operating in the vitamin D therapy market are introducing innovative products to sustain their position in the market. For instance, in February 2021, DSM Pharma Solutions, a Netherlands-based pharmaceutical company, launched a new vitamin D3 powder. Vitamin D3 is associated with bone and muscle health and plays a role in supporting healthy immune function. Getting sufficient levels of vitamin D in the body can be challenging due to limited food sources and a person's direct exposure to sunlight. Even with an intake of traditional vitamin D supplements like D3 or fortified foods, it can still take several months to achieve healthy vitamin D levels in the bloodstream, the company argues. Vitamin D3 is associated with bone and muscle health and plays a role in supporting healthy immune function.

In February 2020, BetterLife Pharma, a Canada-based biotechnology company focused on developing and commercializing patient-friendly compounds to treat neuropsychiatric and neurological disorders acquired Solmic AG for an undisclosed amount. This acquisition is expected to commercialize products that deliver orally bioavailable CBD (cannabidiol) like no other product currently on the market. Solmic AG is a Switzerland-based company that has a unique global patent for the production of new-generation CBD-based biopharmaceuticals.

The countries covered in the vitamin D therapy market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The vitamin D therapy market research report is one of a series of new reports from The Business Research Company that provides vitamin D therapy market statistics, including vitamin D therapy industry global market size, regional shares, competitors with vitamin D therapy market share, detailed vitamin D therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the vitamin D therapy industry. This vitamin D therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.